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ABSTRACT
The PDBSite database provides comprehensive
structural and functional information on various pro-
tein sites (post-translational modification, catalytic
active,organicandinorganicligandbinding,protein–
protein, protein–DNA and protein–RNA interactions)
in the Protein Data Bank (PDB). The PDBSite is avail-
able online at http://wwwmgs.bionet.nsc.ru/mgs/
gnw/pdbsite/. It consists of functional sites extracted
from PDB using the SITE records and of an additional
set containing the protein interaction sites inferred
from the contact residues in heterocomplexes. The
PDBSite was set up by automated processing of the
PDB. The PDBSite database can be queried through
the functional description and the structural charac-
teristics of the site and its environment. The PDBSite
is integrated with the PDBSiteScan tool allowing
structural comparisons of a protein against the func-
tional sites. The PDBSite enables the recognition of
functional sites in protein tertiary structures, provid-
ing annotation of function through structure. The
PDBSite is updated after each new PDB release.
INTRODUCTION
Recognition of functional sites in proteins is a direct computa-
tional approach to the characterization of proteins in terms of
biological and biochemical function. Over the years, it
appeared that the three-dimensional (3D) coordinates can
not only give hints on the protein’s function, but also reveal
it. Search for areas in the protein 3D structure showing struc-
tural similarity to the functional sites of other proteins,
emerged full of promise. The repertoire of software tools
kept growing to include the PROCAT database of the active
site 3D templates (1), programs JESS (2) and TESS (3) for
comparisons of the templates against the target protein; the
PINTS program, which combines the database of functionally
relevant patterns with a tool for local structural patterns search
in the protein 3D structures (4). The ASSAM (5) and RIGOR
(6) programs, among others, retrieve 3D motif matches.
Other approaches compare the target protein surface against
a database of binding site surfaces. With Schmitt’s approach
(7), the putative binding sites are ﬁrst automatically extracted
from a structure, then characterized by descriptors in terms of
physicochemical properties. Subsequently, the RELIBASE
was developed to search for equivalents with regard to both
shape and physicochemical properties (8). There exists a
method for comparing the electrostatic surfaces of proteins
against the eF-site database, with the expectation of identify-
ingdistantlyrelated bindingsites (9)andamorerecent method
for predicting nucleic acid binding sites relying on surface
patches (10).
We have developed the PDBSiteScan program for fast com-
parisons of the protein 3D structure against the functional site
database (11). The algorithm is efﬁcient enough to enable
high-performance search in real-time in databases containing
known protein functional sites. The PDBSiteScan program
compares the 3D protein structure using the backbone
atoms (N, Ca and C). We chose this deliberately to avoid
the possible structural differences between a site template
and a target-protein due to ligand-induced conformational
changes in a site template. Conformational differences can
truly arise because it is common practice to use protein–ligand
complexes for building binding site templates. Ligand-
induced conformational changes are relevant to the prediction
of protein–ligand interactions (12). We have shown that
the PDBSiteScan approach is highly sensitive and speciﬁc
in site recognition; thus, at certain values of the maximal
distance mismatch (MDM) cut-off, sensitivity was 90% and
speciﬁcity was almost 100% in cross-validation analysis of
active site recognition in the hydrolase superfamily (11).
Here, we present a web-accessible PDBSite database of
annotated protein functional sites. One goal was structural
comparison of target protein against known functional sites,
the other was to provide a ﬂexible search for proteins on the
basis of description of their functional sites. The PDBSiteScan
program was integrated into PDBSite to reach the ﬁrst goal.
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of the sites were included in the PDBSite, thereby providing
the database retrieval. Efforts were made to offer the structural
biologists opportunities to set up functional site samples meet-
ing various criteria.
The environment of the sites can be important for their
function (13). In fact, relationships between protein activities
and physicochemical characteristics of functional site envir-
onment have been observed (14). It made sense to include the
spatial environment calculated for the functional sites in
PDBSite in the hope that the information would be useful
for site recognition and delving into their function.
We applied PDBSite for searching novel functional sites in
the mutants of the DNA-binding domain of the human protein
p53 resulting from tumor-associated mutations. It was found
that the G245C mutation gives rise to the zinc binding site,
which partly overlaps the normal Zn
2+ binding site. It was
suggested that the extra Zn
2+ binding site can compete with
the normal site for zinc binding, thereby affecting the speci-
ﬁcityofp53bindingtoDNA.Quite obviously,PDBSitecanbe
useful in tackling a wide range of tasks related to structural
genomics and more speciﬁcally to structure-based drug
design.
METHODS
The Protein Data Bank (PDB) ﬁelds HEADER, TITLE,
KEYWDS, REMARK 800, SITE and ATOM were automa-
tically processed to generate the PDBSite database. A descrip-
tion of the PDBSite database ﬁelds is available in the
Supplementary Material. A PDB entry could contain data
on a number of sites; if so, a separate entry was generated
in the PDBSite to accommodate every one of the sites.
To generate the description of proteins for site retrieval, the
HEADER, TITLE and KEYWDS ﬁelds of the PDB were used.
The textual descriptions of the site functions were extracted
from the REMARK 800 ﬁeld. A program was developed for
data mining of the functional type of sites in the textual
descriptions. Functionalsites of 180 types couldbe classiﬁed
by the current version of the program. All sites that eluded our
classiﬁcation were referred to the Unclassiﬁed group.
Besides the sites retrieved from the PDB using the SITE
ﬁeld, the protein interaction sites with protein, RNA and
DNA, inferred from the calculated contact residues in hetero-
complexes, are regularly updated. The PDB heterocomplexes
denoted by the word COMPLEX in the HEADER ﬁeld were
processed.Weusedcontactsonlybetweenthedifferentproteins
foridentifyingtheprotein–proteininteractionsites.Thesubunit
contactsofthesameproteinwereignoredinthecurrentversion
of the PDBSite database. Biological and asymmetric units
werenotgenerated.TheatomiccoordinatesdeﬁnedinPDBwere
used without transformation. A residue having at least three
atoms whose distance from any atom of the partner chain <5 s
was treated as a contact (15). The sites for protein– DNA and
protein–RNA interactions were deﬁned in a similar way.
Thespatialenvironment ofthe sites was calculatedbydeﬁn-
ing the residues in contact with the site residues. In this case,
two residues were considered as contact if the distance
between at least one atom pair, assigned to different residues,
did not exceed 5 s (16).
The spatial moment of the physicochemical property was
calculated as
SM =
X N
i=1
hixi
"# 2
+
X N
i=1
hiyi
"# 2
+
X N
i=1
hizi
"# 2 8
<
:
9
=
;
1=2
, 1
where hi (i = 1, 2,..., N) is the value for the physicochemical
property of the i-th site residue (e.g. hydrophobicity); N is
number of site residues; xi, yi and zi are the coordinates of
the Ca atom of the i-th residue. The atomic coordinates was
transformed relative to the geometric center of the site before
calculating SM.
Site discontinuity in the protein primary structure was
written as
Discontinuity =
1
N
X N
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piþ1   pi   1 ðÞ , 2
where N denotes the site residue number, pi is the order num-
ber of the i-th residue of the site in the protein sequence.
The value expresses the average position number in primary
structure between two neighbor site residues. To illustrate, if
the site consists of a discontinuous sequence fragment, its
estimated discontinuity index is 0.
DATABASE ACCESS
The database is available online at http://wwwmgs.bionet.
nsc.ru/mgs/gnw/pdbsite/. The web page has a link to the
Sequence Retrieval System (SRS) search in the PDBSite
and a link to the PDBSiteScan program. SRS provides search
tools that enable the user to retrieve functional sites using site
characteristics. The PDBSiteScan searches by structural com-
parisons of a protein against a database functional site (11).
DISCUSSION
PDBSite statistics
The number of entries in the current release of the PDBSite
database now stands at 10 204. The functional sites are
subdivided into eight groups by their site description (see
Table 1). Each group, in turn, is divided into subgroups by
Table 1. Grouping of functional site types in the PDBSite database
Groups of functional sites Number of specific
functions per group
Number of sites
per group
Active
a 222 1467
Post-translational
modification
85 5
Ion metal binding 17 1506
Inorganic non-metal binding 9 657
Organic ligand binding 133 1130
Protein–protein interaction 995 1002
Protein–DNA interaction 1324 1329
Protein–RNA interaction 752 755
Pharmaceutical drug binding 14 28
Miscellaneous — 2303
aThe number of specific functions was estimated as the counts of unique EC
enzymes from which the sites were extracted.
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subgroups, we singled out another group for the binding
sites of pharmaceutical drugs. This group contains protein
sites binding to organic compounds and proteins known to
be medically relevant. The speciﬁc functions of the sites
are given in the SITE_TYPE ﬁeld (see the Supplementary
Material). As shown in the table, the PDBSite contains a
representative number of sites and it can be used for protein
functional annotation. The PDBSite database actually contains
a much greater number of functional site types than listed
in Table 1. A substantial number of sites have eluded our
classiﬁcation and they were assigned to the Miscellaneous
group in the table. Descriptions of site functions in the
PDB database are often incomplete or poorly formalized.
To do this better, additional information on their structure
or their binding ligands is required. Nevertheless, these
sites can be useful in protein annotation. Many of the sites
contain descriptions that are not computer-readable, yet under-
standable to the user.
Annotation of mutant proteins
The annotation of mutant proteins with altered function
resulting from natural mutations, e.g. single nucleotide
polymorphism (17), is highlighted in structural genomics. It
is axiomatic that genetic variation (mutation) is the basis
behind both susceptibility to disease and response to drugs.
The conventional approaches to function identiﬁcation relying
on search for homologous proteins are inapplicable to mutant
protein annotation. With this in mind, we performed an ana-
lysis oftumorigenic mutationsin the human p53 DNA-binding
domain (DBD).
Mechanisms as to how tumorigenic DBD mutations
undeniably cause reduction in p53 site-speciﬁc DNA-binding
activity (18,19) were thought provoking: just by eliminating
critical protein–DNA contact like R273H (20–22), by
lowering thermodynamic stability to the level at which
DBD is predicted to be for the most part unfolded, like
R175H (23), or most likely by enhancing loss of the single
bound Zn
2+ ion (24,25).
In this analysis, we proceeded on the basic assumption that
certain mutations can give rise to novel functional sites. The
data on the p53 gene mutations were retrieved from the Swiss-
Prot database [AC P04637, (26)]. The tertiary structures of
the p53 mutants were calculated using the SWISS-MODEL
server (27).
We found new extra functional sites in a number of mutant
proteins. To illustrate, we revealed an extra zinc binding site
that overlaps the normal zinc binding site in the mutant pro-
tein, G245C. According to the X-ray crystal structure of DBD
(PDB ID 1gzh), Zn
2+ is coordinated to C176, H179, C238 and
C242 residues. The mutation G245C gives rise to a new site
Figure 1. Superposition of the DNA-binding domain of human p53 (PDB ID 1gzh) to the Zn
2+ binding site cytidine deaminase (PDB ID 1AF2). The cytidine
deaminasesiteishighlightedingreen.ThenormalpositionoftheZn
2+ionisshownasablue-coloredball.ThenewpotentialpositionoftheZn
2+,incaseanextrazinc
binding site results from G245C mutation, is represented as a circle. The numbering of residues with their single-letter code is given for p53.
Nucleic Acids Research, 2005, Vol. 33, Database issue D185(H179, C242 and C245) similar in structure to the site for Zn
2+
cytidine deaminase binding [PDB ID 1af2 (Figure 1)].
The mutation G245C was found in families with the
Li-Fraumeni syndrome (28). On analysis of the functional
signiﬁcance of this germline mutation, it was concluded
that malignant cells lose tumor-suppressor activity (29).
Our results suggest a molecular mechanism for the effect of
the G245C substitution based on competition between normal
and extra sites for Zn
2+ binding. The molecular mechanism
will remain conjectural until experimentally veriﬁed. If we are
correct in regarding the novel site as extra Zn
2+ binding, it can
be a useful target in structure-based drug design.
PERSPECTIVES
The strategic consideration is: how to improve the method of
functional site recognition? This will be a collaborative endea-
vour: our approach in conjunction with other approaches to
functional site prediction. Beneﬁts would be expected from
broader approaches combining those based on structure alone,
such as the exemplary THEMATICS (30,31), with those based
on structural comparisons. We are striving to develop easy-
to-use tools for the functional annotation of proteins when
information on their homologs in scant. We envisage
achieving this through incorporation; emphasis will be on
integration of PDBSite into the protocols of functional protein
annotation.
FUTURE DEVELOPMENTS
We intend to classify more completely the sites in the PDBSite
database by their function. This will be achieved by expanding
PDBSite to include information about ligands obtained
through analyses of their complexes with proteins in the
PDB; an approach based on structural comparisons of target
sites against sites of clearly deﬁned function will be imple-
mented. A pharmaceutical description of drug and drug-like
ligands that may have diagnostic or functional utility adapted
from the data in the literature will be provided.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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